Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
20406046
DOI
10.33549/physiolres.931797
PII: 931797
Knihovny.cz E-zdroje
- MeSH
- chronická nemoc MeSH
- daunomycin toxicita MeSH
- fibróza MeSH
- hydroxyprolin metabolismus MeSH
- kardiomyopatie * chemicky indukované metabolismus prevence a kontrola MeSH
- kardiovaskulární látky farmakologie MeSH
- kolagen metabolismus MeSH
- králíci MeSH
- lékové interakce MeSH
- matrixová metaloproteinasa 2 metabolismus MeSH
- matrixová metaloproteinasa 9 metabolismus MeSH
- modely nemocí na zvířatech MeSH
- myokard enzymologie patologie MeSH
- protinádorová antibiotika toxicita MeSH
- razoxan farmakologie MeSH
- remodelace komor fyziologie MeSH
- zvířata MeSH
- Check Tag
- králíci MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- daunomycin MeSH
- hydroxyprolin MeSH
- kardiovaskulární látky MeSH
- kolagen MeSH
- matrixová metaloproteinasa 2 MeSH
- matrixová metaloproteinasa 9 MeSH
- protinádorová antibiotika MeSH
- razoxan MeSH
The matrix metalloproteinases (MMPs) play a key role during cardiac remodeling. The aim of the study was to investigate the changes in collagenous proteins and MMPs in the model of non-ischemic, anthracycline-induced chronic cardiomyopathy in rabbits using both biochemical and histological approaches. The study was carried out in three groups of Chinchilla male rabbits: 1) daunorubicin (3 mg/kg, once weekly for 10 weeks), 2) control (saline in the same schedule), 3) daunorubicin with the cardioprotectant dexrazoxane (60 mg/kg, before each daunorubicin). Morphological changes in the myocardium of daunorubicin-treated animals were characterized by focal myocardial interstitial fibrosis of different intensity. The subsequent proliferation of the fibrotic tissue was marked by an increased content of both collagen types I and III, which resulted in their typical coexpression in the majority of bundles of fibers forming either smaller or larger scars. Biochemical analysis showed a significantly increased concentration of hydroxyproline, mainly in the pepsin-insoluble fraction of collagenous proteins, in the daunorubicin-treated group (1.42+/-0.12 mg/g) as compared with the control (1.03+/-0.04 mg/g) and dexrazoxane (1.07+/-0.07 mg/g) groups. Dexrazoxane co-administration remarkably reduced the cardiotoxic effects of daunorubicin to the extent comparable with the controls in all evaluated parameters. Using zymography, it was possible to detect only a gelatinolytic band corresponding to MMP-2 (MMP-9 activity was not detectable). However, no significant changes in MMP-2 activity were determined between individual groups. Immunohistochemical analysis revealed increased MMP-2 expression in both cardiomyocytes and fibroblasts. Thus, this study has revealed specific alterations in the collagen network in chronic anthracycline cardiotoxicity in relationship to the expression and activity of major MMPs.
Citace poskytuje Crossref.org